Inventor · disambiguated record
Elisabeth Buchdunger
Also filed as: BUCHDUNGER ELISABETH
4 granted patents·6 pending applications·48 citations·filing 2001–2013
76Inventor score
Technology areasA61P
Top patents by PatentIndex Score
10 records- 0183US6958335B2Treatment of gastrointestinal stromal tumorsUNIV OREGON HEALTH & SCIENCE·Filed 2001·Granted Oct 25, 2005·34 cites·6 claims
- 0278US8124611B2Inhibitors of the mutant form of kitBUCHDUNGER ELISABETH·Filed 2010·Granted Feb 28, 2012·6 cites·2 claims
- 0373US8017621B2Inhibitors of the mutant form of kitNOVARTIS AG·Filed 2004·Granted Sep 13, 2011·6 cites·12 claims
- 0462US7723339B2Combination comprising a signal transduction inhibitor and an epothilone derivativeNOVARTIS AG·Filed 2002·Granted May 25, 2010·2 cites·10 claims
- 0560US2009202541A1Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl)-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agentBRUNS CHRISTIAN·Filed 2009·Application pending·0 cites
- 0654US2011124670A1Use of Pyrimidylaminobenzamide Derivatives for the Treatment of FibrosisBUCHDUNGER ELISABETH·Filed 2009·Application pending·0 cites
- 0750US2012283206A1Combination comprising N--4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent.BRUNS CHRISTIAN·Filed 2012·Application pending·0 cites
- 0847US2004167134A1Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agentFiled 2002·Application pending·0 cites
- 0945US2012157441A1Inhibitors of the mutant form of kitBUCHDUNGER ELISABETH·Filed 2012·Application pending·0 cites
- 1044US2013267549A1Use of Pyrimidylaminobenzamide Derivatives for the Treatment of FibrosisBUCHDUNGER ELISABETH·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elisabeth Buchdunger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →